Cargando…

Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results

BACKGROUND: While electroconvulsive therapy (ECT) has been used for many years, there is insufficient research regarding the indications for continuation/maintenance (C/M)-ECT, its safety and efficacy, and the characteristics of patients with schizophrenia or schizoaffective disorder who receive mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Iancu, Iulian, Pick, Nimrod, Seener-Lorsh, Orit, Dannon, Pinhas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384746/
https://www.ncbi.nlm.nih.gov/pubmed/25848283
http://dx.doi.org/10.2147/NDT.S78919
_version_ 1782364952493817856
author Iancu, Iulian
Pick, Nimrod
Seener-Lorsh, Orit
Dannon, Pinhas
author_facet Iancu, Iulian
Pick, Nimrod
Seener-Lorsh, Orit
Dannon, Pinhas
author_sort Iancu, Iulian
collection PubMed
description BACKGROUND: While electroconvulsive therapy (ECT) has been used for many years, there is insufficient research regarding the indications for continuation/maintenance (C/M)-ECT, its safety and efficacy, and the characteristics of patients with schizophrenia or schizoaffective disorder who receive multiple ECT sessions. The aims of this study were to characterize a series of patients who received 30 ECT sessions or more, to describe treatment regimens in actual practice, and to examine the results of C/M-ECT in terms of safety and efficacy, especially the effect on aggression and functioning. METHODS: We performed a retrospective chart review of 20 consecutive patients (mean age 64.6 years) with schizophrenia (n=16) or schizoaffective disorder (n=4) who received at least 30 ECT sessions at our ECT unit, and also interviewed the treating physician and filled out the Clinical Global Impression-Severity, Global Assessment of Functioning, and the Staff Observation Aggression Scale-Revised. RESULTS: Patients received a mean of 91.3 ECT sessions at a mean interval of 2.6 weeks. All had been hospitalized for most or all of the previous 3 years. There were no major adverse effects, and cognitive side effects were relatively minimal (cognitive deficit present for several hours after treatment). We found that ECT significantly reduced scores on the Staff Observation Aggression Scale-Revised subscales for verbal aggression and self-harm, and improved Global Assessment of Functioning scores. There were reductions in total aggression scores, subscale scores for harm to objects and to others, and Clinical Global Impression-Severity scores, these were not statistically significant. CONCLUSION: C/M-ECT is safe and effective for chronically hospitalized patients. It improves general functioning and reduces verbal aggression and self-harm. More research using other aggression tools is needed to determine its effects and to reproduce our findings in prospective and controlled studies.
format Online
Article
Text
id pubmed-4384746
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-43847462015-04-06 Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results Iancu, Iulian Pick, Nimrod Seener-Lorsh, Orit Dannon, Pinhas Neuropsychiatr Dis Treat Original Research BACKGROUND: While electroconvulsive therapy (ECT) has been used for many years, there is insufficient research regarding the indications for continuation/maintenance (C/M)-ECT, its safety and efficacy, and the characteristics of patients with schizophrenia or schizoaffective disorder who receive multiple ECT sessions. The aims of this study were to characterize a series of patients who received 30 ECT sessions or more, to describe treatment regimens in actual practice, and to examine the results of C/M-ECT in terms of safety and efficacy, especially the effect on aggression and functioning. METHODS: We performed a retrospective chart review of 20 consecutive patients (mean age 64.6 years) with schizophrenia (n=16) or schizoaffective disorder (n=4) who received at least 30 ECT sessions at our ECT unit, and also interviewed the treating physician and filled out the Clinical Global Impression-Severity, Global Assessment of Functioning, and the Staff Observation Aggression Scale-Revised. RESULTS: Patients received a mean of 91.3 ECT sessions at a mean interval of 2.6 weeks. All had been hospitalized for most or all of the previous 3 years. There were no major adverse effects, and cognitive side effects were relatively minimal (cognitive deficit present for several hours after treatment). We found that ECT significantly reduced scores on the Staff Observation Aggression Scale-Revised subscales for verbal aggression and self-harm, and improved Global Assessment of Functioning scores. There were reductions in total aggression scores, subscale scores for harm to objects and to others, and Clinical Global Impression-Severity scores, these were not statistically significant. CONCLUSION: C/M-ECT is safe and effective for chronically hospitalized patients. It improves general functioning and reduces verbal aggression and self-harm. More research using other aggression tools is needed to determine its effects and to reproduce our findings in prospective and controlled studies. Dove Medical Press 2015-03-27 /pmc/articles/PMC4384746/ /pubmed/25848283 http://dx.doi.org/10.2147/NDT.S78919 Text en © 2015 Iancu et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Iancu, Iulian
Pick, Nimrod
Seener-Lorsh, Orit
Dannon, Pinhas
Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
title Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
title_full Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
title_fullStr Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
title_full_unstemmed Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
title_short Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
title_sort patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384746/
https://www.ncbi.nlm.nih.gov/pubmed/25848283
http://dx.doi.org/10.2147/NDT.S78919
work_keys_str_mv AT iancuiulian patientswithschizophreniaorschizoaffectivedisorderwhoreceivemultipleelectroconvulsivetherapysessionscharacteristicsindicationsandresults
AT picknimrod patientswithschizophreniaorschizoaffectivedisorderwhoreceivemultipleelectroconvulsivetherapysessionscharacteristicsindicationsandresults
AT seenerlorshorit patientswithschizophreniaorschizoaffectivedisorderwhoreceivemultipleelectroconvulsivetherapysessionscharacteristicsindicationsandresults
AT dannonpinhas patientswithschizophreniaorschizoaffectivedisorderwhoreceivemultipleelectroconvulsivetherapysessionscharacteristicsindicationsandresults